130,930 research outputs found

    Het lyden van onsen saligmaker Jesus-Christus /

    No full text
    Vingerafdruk: v.1: 171508 - # b1 A d : # b2 2M2 ttetedoVingerafdruk: v.2: 171508 - # b1 A a : # b2 2L2 y$do1. Behelsende t'Lyden [...] gedurende syn verborgen en openbaer leven. -- 2. Behelsende 't Lyden [...] geduerende syne passie ende syne doodtSTCVHerkomst: Joannes Philippus Bauwens ; Ex libris Joannis Francisci van Wambeke, notaris ... 10 7ber 1767 ... te Aelst ; Desen boek behoort toe aen J. B. Teirlinck ... tot Aelst 1803Backer-Sommervogel [S.J.], I, 179, nr. 4 (col.181) ('4 vol.')Vanderhaeghen, F. Bib. gantoise 1925Europeana-GoogleBook

    Immunotherapy

    No full text
    A chapter covering metastasis immunotherapy in multi-author volume devoted to all aspects of cancer metastasis

    The Ongoing Ebola Epidemic in the Democratic Republic of the Congo: Contributing Factors that have Influenced Disease Control

    No full text
    Ebolavirus outbreaks and epidemics have affected regions of Africa since its discovery in 1976. Presently, the Democratic Republic of the Congo (DRC) is experiencing its tenth and largest outbreak of Ebolavirus, infecting nearly 3,432 individuals and causing 2,253 deaths. First declared an official outbreak on August 1, 2018, the DRC Ministry of Health (MOH) and other global health institutions are having difficulties in controlling the spread of infection due to community resistance and mistrust, poor healthcare infrastructures, political conflict, civil unrest, and porous geographic boundaries. A literature review and analysis were performed to evaluate contributing factors to the ongoing outbreak in the DRC. In this essay, I outline the contributing factors that have led to the continuity of the ebolavirus epidemic in the DRC and predict long-term effects it may have on the country. By analyzing up-to-date World Health Organization (WHO) situation reports, journal articles, and newspaper reports, I have found that in order to sufficiently control the outbreak, continued surveillance and contact tracing is required in combination with building community trust and transparency. It is important to understand outbreak and infection control measures in historically underdeveloped areas, especially those with poor healthcare infrastructure and politically unstable environments. By gaining insight on the successes and shortcomings of specific public health control measures, health ministries and global health organizations can improve upon their actions and distribution of resources in times of dangerous outbreaks

    MeSH term explosion and author rank improve expert recommendations

    No full text
    Information overload is an often-cited phenomenon that reduces the productivity, efficiency and efficacy of scientists. One challenge for scientists is to find appropriate collaborators in their research. The literature describes various solutions to the problem of expertise location, but most current approaches do not appear to be very suitable for expert recommendations in biomedical research. In this study, we present the development and initial evaluation of a vector space model-based algorithm to calculate researcher similarity using four inputs: 1) MeSH terms of publications; 2) MeSH terms and author rank; 3) exploded MeSH terms; and 4) exploded MeSH terms and author rank. We developed and evaluated the algorithm using a data set of 17,525 authors and their 22,542 papers. On average, our algorithms correctly predicted 2.5 of the top 5/10 coauthors of individual scientists. Exploded MeSH and author rank outperformed all other algorithms in accuracy, followed closely by MeSH and author rank. Our results show that the accuracy of MeSH term-based matching can be enhanced with other metadata such as author rank

    Going Beyond Counting First Authors in Author Co-citation Analysis

    No full text
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    "Closing the R&D Gap, Evaluating the Sources of R&D Spending"

    No full text
    Both spending and tax policies have been implemented in the United States with the goal of stimulating private sector research and development (R&D). Karier questions whether current R&D policy, especially the research and experimentation tax credit, can contribute to closing the gap between nondefense expenditures on R&D in the United States and such expenditures in other countries, such as Japan and Germany. He also explores possible changes to our current R&D policy to make it more effective.

    Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA)

    No full text
    <p><b>Background and Purpose:</b> Baseline stroke severity predicts outcomes among thrombolysed patients. The baseline National Institutes of Health Stroke Scale (NIHSS) thresholds are sometimes used to select patients for thrombolysis, clinical trial enrollment, or both. Using data lodged with Virtual International Stroke Trials Archive, we compared adjusted outcomes between thrombolysed and nonthrombolysed patients enrolled in neuroprotection trials (1998-2007) to assess the influence of various levels of baseline NIHSS.</p> <p><b>Method:</b> We assessed the association of treatment with outcome, measured across the modified Rankin scale score distribution, in patients categorized by baseline NIHSS in increments of 4. We used an age and baseline NIHSS adjusted Cochran-Mantel-Haenszel test followed by proportional odds logistic regression analysis. We report the Cochran-Mantel-Haenszel P values and estimated odds ratios (OR) for improved modified Rankin scale score distribution with treatment for patients within each baseline NIHSS category.</p> <p><b>Results:</b> Data were available for 5817 patients (1585 thrombolysed and 4232 nonthrombolysed). Baseline severity was greater among thrombolysed than nonthrombolysed (median baseline NIHSS, 14 vs 13; P<0.05). An association of treatment with outcome was seen independently and was of similar magnitude within each of the baseline NIHSS categories 5 to 8 (P=0.04; OR, 1.25; 95% confidence interval [CI], 1.0-1.6; N=278/934 thrombolysed/nonthrombolysed), 9 to 12 (P=0.01; OR, 1.3; 95% CI, 1.1-1.6; N=404/942), 13 to 16 (P<0.05; OR, 1.6; 95% CI, 1.3-2.1; N=342/814), 17 to 20 (P<0.05; OR, 1.7; 95% CI, 1.3-2.1; N=311/736), and 21 to 24 (P<0.05; OR, 1.6; 95% CI, 1.1-2.1; N=178/466). No association was observed within baseline NIHSS categories 1 to 4 (P=0.8; OR, 1.1; 95% CI, 0.3-4.4; N=8/161) or >= 25 (P=0.08; OR, 1.1; 95% CI, 0.7-1.9; N=64/179).</p> <p><b>Conclusions:</b> In this nonrandomized comparison, outcomes after thrombolysis were significantly better than in untreated comparators across baseline NIHSS 5 to 24. The significant association was lost only at extremes of baseline NIHSS when sample sizes were small and confidence limits were wide.</p&gt

    A. D. Fricke, author

    No full text
    Black and white photograph of author, A. D. Fricke

    Dispelling the Myths Behind First-author Citation Counts

    No full text
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods

    Scholarly Communication and Publishing Lunch and Learn Talk #11: The ULS Open Access Author Fee Fund

    No full text
    At the May 2014 talk, you will learn about the ULS Open Access Author Fee Fund--what it is, why we do it, how it works, and how the program is going so far
    corecore